Eli Lilly Annual Meeting Sees Directors Win, Governance Changes Fail Amid 45% Revenue Jump

At Eli Lilly's annual meeting, directors were re-elected while proposed governance changes failed to pass, with CEO David Ricks highlighting a significant 45% jump in revenue for the pharmaceutical giant.